Shana Kelley, CTRL Therapeutics founder and chief technology officer

A new cell ther­a­py biotech emerges to find sol­id tu­mor-killing im­mune cells in pa­tients' blood

A new au­tol­o­gous cell ther­a­py mak­er is com­ing to the fore with $10 mil­lion to start.

Chica­go-based CTRL Ther­a­peu­tics hopes to ex­pand be­yond the cur­rent …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA